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A great deal of biomedical research focuses on new biotechnologies such as gene editing, stem cell biology, 
and reproductive medicine, which have created a scientific revolution. While the potential medical benefits 
of this research may be far-reaching, ethical issues related to non-medical applications of these technologies 
are demanding. We analyze, from a Jewish legal perspective, some of the ethical conundrums that society 
faces in pushing the outer limits in researching these new biotechnologies. 
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INTRODUCTION 
Society is in the midst of a technological revolution, 
especially in reproductive medicine and molecular 
genetics, areas that hold the promise of improving 
human health in unimaginable ways. In 2017, for 
example, scientists have applied gene-editing 
(clustered regularly interspaced short palindromic 
repeats, referred to as CRISPR) technology to correct 
the genetic cause of a fetal heart disease, hypertro-
phic cardiomyopathy, and a common blood disease, 
β-thalassemia.1,2 The use of this technology in utero 
can enable babies to be born without these serious 
and sometimes fatal diseases. Another example of 
potentially life-saving advances in biotechnology and 
 
organ transplantation is using human stem cells to 
create chimeric pigs that develop human organs.3–5  
These scientific achievements are both exciting 
and ethically challenging.6,7 The excitement is the 
hope that gene-editing technology can be useful in 
correcting some of the over 10,000 mutations that 
can cause human disease. Creating chimeric human-
pigs offers a unique opportunity for people whose 
own livers, kidneys, or hearts are irreversibly failing, 
to safely receive organs donated from animals.  
The ethical concerns regarding these biotech-
nologies are many. Will society limit their use to 
 
Outer Limits of Biotechnologies 
 
 
Rambam Maimonides Medical Journal 2 January 2018  Volume 9  Issue 1  e0008 
 
curing disease, or will also people begin to use tech-
nology for non-medical purposes? Creating “designer 
babies” such as those with particular facial struc-
tures or enhanced intelligence is one such concern 
that has been problematic since the days of the 
original 1967 Star Trek episode, “Space Seed” (which 
inspired the film Star Trek II: The Wrath of Khan). 
Another group of science fiction writers who penned 
Planet of the Apes note that there is also a fear of 
creating animals with reconstituted human brains or 
human speech and of placing people at risk of 
unknown side effects. Moreover, some people 
believe that such technologies are unethical because 
they enable human beings to “play God” by tamper-
ing with the holy genetic grail or interfering with the 
normal evolution of species.  
BALANCING SCIENTIFIC INNOVATION 
WITH ETHICAL CONCERNS 
How should society balance the innate human desire 
to innovate new technologies with the fear that their 
applications may violate ethical norms? While these 
debates are ongoing, current United States govern-
ment guidelines ban the use of federal funds to 
modify embryos using technologies such as CRISPR. 
If science has the capacity to save lives through such 
technology, are we ethically justified in not moving 
this forward?  
When viewed through the Jewish lens of the 
Bible (written law) and the Talmud (oral law), there 
is precedent for legal and moral deliberations of this 
kind. Jewish philosophy and law have debated simi-
lar issues over the past two thousand years and offer 
meaningful guidelines that address the question of 
balancing scientific discovery with the fear of 
unethical applications. Great rabbinical thinkers 
from Nachmanides (thirteenth century) to Rabbi 
Joseph Soloveitchik (twentieth century) stated that 
God created an incomplete world in which human 
beings must utilize their creative capacities to 
complete the creation process. In other words, God 
directed human beings to partner with Him to finish 
the creation process.8–10  
PLAYING GOD—MORAL IMPERATIVE? 
The lessons from these discussions relate most pro-
foundly to current times. We propose that a Divine 
directive is for human society to embrace science by 
actively supporting the research of natural law and 
applying it wisely. This Divine directive represents a 
universal directive for all humanity. Clearly, the Bible 
and Talmud understood that human inhabitation of 
this world requires scientific research that encom-
passes biology, chemistry, and physics to enable hu-
man beings to live in an environmentally, biological-
ly, and medically healthy society. Thus, the concept 
of human beings “playing God” can be viewed as an 
ethical principle not an immoral activity. 
Judaism recognizes that scientific research begins 
by understanding basic principles underlying bio-
logical and cellular processes through observation of 
the wide variety of biological life. Biological prece-
dent is an important guideline in both scientific 
discovery and applications. In fact, scientists incor-
porate this philosophical approach today. Gene 
editing is one example of a scientific discovery that 
originated from basic research in virology that 
showed how a simple bacterium can protect itself 
from an invading virus.11  
Jewish law also presents a profound directive 
from the classical moral objective that one is obli-
gated to “refrain from doing bad and do good.”12,13 
Judaism believes that the ideal objective is to trans-
form the evil into goodness. The Talmud states that 
the answers to curing human diseases lie within the 
laws of nature because God created the cures for all 
diseases even before He created disease pathology.14 
There is no better example of this concept than what 
we are currently witnessing in the excitement 
surrounding immunotherapy and cancer.15 Under-
standing why our immune system fails to fight 
tumors has enabled scientists to re-educate our T 
cells to fight and destroy lethal cancers. 
A PATH FOR ETHICAL ANALYSIS 
The challenge is how to apply scientific research in 
practice in a morally acceptable manner. The Su-
preme Court of Jewish Law would always address 
religious legal questions at two levels in a manner 
similar to how the US supreme court deals with dif-
ficult cases.16,17 The first level was a general, theoret-
ical legal analysis of the history of law and how the 
populace practiced the parameters of a law. The 
second level was a practical and particular approach, 
examining each situation according to the individual 
circumstances and developing the response accord-
ing to the specific details and characteristics of that 
situation. Indeed, Jewish law places a much greater 
emphasis on the latter principle—each case must be 
evaluated individually on its merits and details. 
We believe there is much merit in this type of 
analysis regarding the new biotechnologies being 
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developed. First, we must ethically analyze the vari-
ous procedures underlying the biotechnology. Does 
it involve harming animals? Does it violate basic prin-
ciples of bioethics? Then, we should address these 
principles as they apply to a particular situation and 
recognize that all technologies, while morally neutral, 
have the potential to do both good and/or to do harm.  
Translational biotechnology, in order to develop 
new therapies for disease, is the ultimate objective 
of science and is part of the Divine directive for 
human beings to partner with God. However, society 
must be careful of the outer limits of technology that 
may be unethical. Do the ethical outer limits of 
technology include non-medical procedures such as 
sex-selection, cosmetic changes (hair or eye color, 
height), or tampering with biological species to cre-
ate new species, such as animals with human neu-
rons, or monkeys with human genes that regulate 
human speech?  
The general rule in Judaism is that gene editing 
for non-medical applications is ethically wrong and 
should not be routinely acceptable. In the case of 
gene-editing a human embryo, we believe it is moral 
and ethical to genetically edit not only an embryo 
carrying lethal genes (e.g. Tay–Sachs) but also in 
cases where the child would be born and burdened 
with serious health issues (e.g. cystic fibrosis).  
The Torah states that its laws are created for 
people to live by, and so we should support medical 
and technological advances that promote the saving 
of lives. We should advocate that society commit sig-
nificant government and private funding to basic 
research. This also includes supporting research for 
creative procedures that protect the weaker segments 
of the population in order to provide fair allocation 
of treatments. We advocate continuing to push the 
limits of scientific research, but at the same time, we 
must not allow the unethical, non-medical applica-
tions. In the realm of new biotechnology, the goal of 
partnering with God to save lives should be 
paramount. It is not what you can do but what you 
should do. 
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